Smart Labels market Analysis and Trends by 2022-2035

josephmorale josephmorale
0
Smart Labels market Analysis and Trends by 2022-2035

Roots Analysis has done a detailed study on Smart Pharmaceutical and Healthcare Labels Market, 2022-2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

 

Key Market Insights

  • The current market landscape features the presence of over 90 players engaged in the smart pharmaceutical and healthcare labels domain, worldwide
  • Over 80 players employ radio frequency identification device-based technology in order to develop cutting-edge labels for a wide range of applications; IoT labels are also gaining traction
  • Smart labels providers are continuously upgrading their existing portfolio and are seeking investments, as well as expanding their intellectual capital, in order to gain an edge in this competitive industry
  • More than 400 patents have been granted / filed for smart pharmaceutical and healthcare labels, primarily led by industry players based in North America
  • A rise in interest in partnerships, in recent past, involving both international and indigenous stakeholders, validate the growing interest in this domain; maximum number of such deals were signed in 2019
  • Based on the pioneer-migrator-settler map, we have classified the smart label providers into different categories; a selection of pioneers is expected to provide valuable offerings to lead the market in the longer term
  • The Smart labels market is expected to witness a healthy growth of over 15% in the coming decade; the opportunity is likely to be well distributed across various technologies and different geographical regions
  • In long term, the majority share of revenues is likely to be driven by players offering smart labels for primary packaging to prevent counterfeiting of drugs

 

Request a free sample of the report

https://www.rootsanalysis.com/reports/smart-labels-market/request-sample.html

 

Table of Contents

 

  1. PREFACE

1.1.             Scope of the Report

1.2.             Market Segmentations

1.3.             Research Methodology

1.4.             Frequently Asked Questions

1.5              Chapter Outlines

 

  1. EXECUTIVE SUMMARY

2.1.             Chapter Overview

 

  1. INTRODUCTION

3.1.             Chapter Overview

3.2.             Role of Smart Labels in the Healthcare Sector

3.2.1           Types of Smart Labels

3.2.1.1.       Radio Frequency Identification Device (RFID)

3.2.1.2.       Near-Field Communication (NFC)

3.2.1.3.       Internet of Things (IoT)

3.2.2.          Need for Smart Labels in the Healthcare Sector

3.2.3.          Advantages of Using Smart Labels in Healthcare Sector

 

3.3.             Roadblocks and Challenges Associated with the Adoption of Smart Labels

3.4.             Adoption of Smart Labels in the Healthcare Sector

3.4.1.          Key Drivers for Adoption of Smart Labels

 

3.5.             Future Outlook

 

  1. MARKET LANDSCAPE

4.1.             Chapter Overview

4.2.             Smart Pharmaceutical and Healthcare Label Providers: Overall Market Landscape

4.2.1.          Analysis by Year of Establishment

4.2.2.          Analysis by Company Size

4.2.3.          Analysis by Location of Headquarters

4.2.4.          Analysis by Company Size and Location of Headquarters

4.2.5.          Analysis by Type of Technology

4.2.6.          Analysis by Company Size and Type of Technology

4.2.7.          Analysis by Type of RFID Frequency Band

4.2.8.          Analysis by Area(s) of Application

4.2.9.          Analysis by Company Size and Area(s) of Application

4.2.10.        Analysis by Type of Technology and Area(s) of Application

 

  1. COMPANY COMPETITIVENESS ANALYSIS

5.1.             Chapter Overview

5.2.             Assumptions / Key parameter

5.3.             Methodology

 

5.3.1.          Smart Pharmaceutical and Healthcare Label Providers based in North America

5.3.2.          Smart Pharmaceutical and Healthcare Label Providers based in Europe

5.3.3.          Smart Pharmaceutical and Healthcare Label Providers based in Asia-Pacific and RoW

 

5.4.             Company Competitiveness Analysis: Benchmarking the Capabilities of Leading Players

 

  1. COMPANY PROFILES

6.1.             Chapter Overview

 

6.2.             CCL Industries

6.2.1.          Company Overview

6.2.2.          Financial Information

6.2.3.          Area(s) of Application

6.2.4.          Recent Developments and Future Outlook

 

6.3.             Schreiner

6.3.1.          Company Overview

6.3.2.          Area(s) of Application

6.3.3.          Recent Developments and Future Outlook

 

6.4.             Datalogic

6.4.1.          Company Overview

6.4.2.          Financial Information

6.4.3.          Area(s) of Application

6.4.4.          Recent Developments and Future Outlook

 

6.5.             Tadbik

6.5.1.          Company Overview

6.5.2.          Area(s) of Application

6.5.3.          Recent Developments and Future Outlook

 

6.6.             SATO Asia Pacific

6.6.1.          Company Overview

6.6.2.          Financial Information

6.6.3.          Area(s) of Application

6.6.4.          Recent Developments and Future Outlook

 

6.7.             Invengo

6.7.1.          Company Overview

6.7.2.          Area(s) of Application

6.7.3.          Recent Developments and Future Outlook

 

6.8.             Intellhydro Technology

6.8.1.          Company Overview

6.8.2.          Area(s) of Application

6.8.3.          Recent Developments and Future Outlook

 

6.9.             RFiD Discovery

6.9.1.          Company Overview

6.9.2.          Area(s) of Application

6.9.3.          Recent Developments and Future Outlook

 

6.10.           ID Tech Solutions

6.10.1.        Company Overview

6.10.2.        Area(s) of Application

6.10.3.        Recent Developments and Future Outlook

 

  1. PATENT ANALYSIS

7.1.             Chapter Overview

7.2.             Scope and Methodology

 

7.3.             Smart Pharmaceutical and Healthcare Labels: Patent Analysis

7.3.1.          Analysis by Publication Year

7.3.2.          Analysis by Publication Year and Type of Patent

7.3.3.          Analysis by CPC Code

7.3.4.          Analysis by Type of Applicant

7.3.5.          Analysis by Geography

7.3.6.          Analysis by Emerging Focus Areas

7.3.7.          Leading Industry Players: Analysis by Number of Patents

 

7.4.             Smart Pharmaceutical and Healthcare Labels: Patent Benchmarking Analysis

7.4.1.          Analysis by Patent Characteristics

7.5.             Smart Pharmaceutical and Healthcare Labels: Patent Valuation Analysis

 

  1. PARTNERSHIPS AND COLLABORATIONS

8.1.             Chapter Overview

8.2.             Partnership Models

8.3.             Smart Pharmaceutical and Healthcare Labels: Recent Partnerships and Collaborations

8.3.1.          Analysis by Year of Partnership

8.3.2.          Analysis by Type of Partnership

8.3.3.          Most Active Players: Analysis by Number of Partnerships

8.3.4.          Regional Analysis

8.3.4.1.       Local and International Agreements

8.3.4.2.       Intercontinental and Intracontinental Agreements

 

  1. BLUE OCEAN STRATEGY: A STRATEGIC GUIDE FOR START-UPS TO ENTER INTO HIGHLY COMPETITIVE MARKET

9.1.             Chapter Overview

 

9.2.             Overview of Blue Ocean Strategy

9.2.1           Red Ocean

9.2.2           Blue Ocean

9.2.3           Comparison of Red Ocean Strategy and Blue Ocean Strategy

 

9.2.4.          Smart Pharmaceuticals and Healthcare Labels: Blue Ocean Strategy and Shift Tools

9.2.4.1.       Value Innovation

9.2.4.2.       Strategy Canvas

9.2.4.3.       Four Action Framework

9.2.4.4.       Eliminate-Raise-Reduce-Create (ERRC) Grid

9.2.4.5.       Six Path Framework

9.2.4.6.       Pioneer-Migrator-Settler (PMS) Map

9.2.4.7.       Three Tiers of Noncustomers

9.2.4.8.       Sequence of Blue Ocean Strategy

9.2.4.9.       Buyer Utility Map

9.2.4.10.     The Price Corridor of the Mass

9.2.4.11.     Four Hurdles to Strategy Execution

9.2.4.12.     Tipping Point Leadership

9.2.4.13.     Fair Process

 

9.3.             Concluding Remarks

 

  1. MARKET SIZING AND OPPORTUNITY ANALYSIS

10.1.           Chapter Overview

10.2.           Key Assumptions and Methodology

10.3.           Global Smart Pharmaceutical and Healthcare Labels Market, 2022-2035

 

10.4.           Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Technology, 2022, 2028 and 2035

10.4.1.        Smart Pharmaceutical and Healthcare Labels Market for RFID, 2022-2035

10.4.2.        Smart Pharmaceutical and Healthcare Labels Market for NFC, 2022-2035

10.4.3.        Smart Pharmaceutical and Healthcare Labels Market for Other Technologies, 2022-2035

 

10.5.           Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Packaging, 2022-2035

10.5.1.        Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Primary Packaging, 2022, 2028 and 2035

10.5.1.1.     Smart Pharmaceutical and Healthcare Labels Market for Vials, 2022-2035

10.5.1.2.     Smart Pharmaceutical and Healthcare Labels Market for Syringes, 2022-2035

10.5.1.3.     Smart Pharmaceutical and Healthcare Labels Market for Cartridges, 2022-2035

10.5.1.4.     Smart Pharmaceutical and Healthcare Labels Market for Ampoules, 2022-2035

10.5.1.5.     Smart Pharmaceutical and Healthcare Labels Market for Bottles, 2022-2035

10.5.1.6.     Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, 2022-2035

 

10.5.2.        Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Secondary Packaging, 2022, 2028 and 2035

10.5.2.1.     Smart Pharmaceutical and Healthcare Labels Market for Boxes, 2022-2035

10.5.2.2.     Smart Pharmaceutical and Healthcare Labels Market for Cartons, 2022-2035

10.5.2.3.     Smart Pharmaceutical and Healthcare Labels Market for Pouches, 2022-2035

 

10.6.           Smart Pharmaceutical and Healthcare Labels Market: Analysis by Geography, 2022and 2035

10.6.1.        Smart Pharmaceutical and Healthcare Labels Market in North America, 2022-2035

10.6.2.        Smart Pharmaceutical and Healthcare Labels Market in Europe, 2022-2035

10.6.3.        Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, 2022-2035

10.6.4.        Smart Pharmaceutical and Healthcare Labels Market in MENA, 2022-2035

10.6.5.        Smart Pharmaceutical and Healthcare Labels Market in Latin America, 2022-2035

 

  1. SWOT ANALYSIS

11.1.           Chapter Overview

11.2.           Strengths

11.3.           Weaknesses

11.4.           Opportunities

11.5.           Threats

11.6.           Comparison of SWOT Factors

 

  1. CONCLUDING REMARKS

 

  1. APPENDIX I: TABULATED DATA

 

  1. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

 

To view more details on this report, click on the link:

https://www.rootsanalysis.com/reports/smart-labels-market.html

 

You may also be interested in the following titles: Oral Solid Dosage Manufacturing Market

Lipid Nanoparticles in Drug Delivery

 

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

                       

Contact:

Ben Johnson

+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

 

 

 

Tags: